Health Technology Access Pool (HTAP) by the WHO

By Danélia Botes

February 19, 2024

WHO’s Health Technology Access Pool

The World Health Organization (WHO) has recently announced the Health Technology Access Pool (HTAP). This serves as a successor to the COVID-19 Technology Access Pool (C-TAP). This initiative marks a significant step towards more equitable access to a broad range of health products. The aim is to enhance global health security.

From C-TAP to HTAP: A Journey of Evolution

Launched in May 2020, C-TAP was a collaborative effort between WHO, the Government of Costa Rica, and other partners. This platform was instrumental in providing a forum for technology partners to share intellectual property, knowledge, and data voluntarily. Despite the challenges of establishing a novel mechanism amidst a pandemic, C-TAP managed to secure six transparent, non-exclusive global licences involving 15 technologies that span research and development (R&D) tools, diagnostics, and vaccines.

Building on C-TAP’s Foundation

HTAP is built on the foundation laid by C-TAP but incorporates structural, process, and other changes to attract and support a diverse range of priority technologies more effectively. It aims to promote access to health products that respond to public health priorities, including pandemic preparedness, and are relevant during and outside health emergencies.

Amplifying Public Health Value

HTAP investments will amplify the public health value and increase the attractiveness of licensed technologies to recipient manufacturers. This approach will realise greater market opportunities and financial sustainability. The announcement on the licensing of a rapid diagnostic test platform technology serves as an example of such an approach.

The Future of HTAP: Awaiting Further Details

In the first quarter of 2024, WHO will publish further details on how HTAP will operate and the technologies it will target. Plans are in place to officially launch HTAP in the second quarter of 2024. In the interim, WHO will adopt the principles and approach described above in evaluating opportunities to secure health technologies and expand regional or global production capacity.

Reference url

Recent Posts

African Medicines Agency development
           

The African Medicine Agency’s Role in Advancing Healthcare

🌍 The #AfricanMedicinesAgency is set to change the face of healthcare in Africa. With a mission to provide quality, safe, and effective medical products, the AMA is a beacon of hope for enhanced health access. 🏥✨ #HealthcareInnovation #GlobalHealth #HealthForAll 💡

🔍 Discover how the AMA’s development is a crucial step towards a healthier continent. 🌐 #AMAdevelopment #AfricanUnion #HealthcareAccess🤝

. 📢 Read our latest article to understand the AMA’s vision, challenges, and the road ahead. Let’s unite for #HealthcareExcellence in Africa! 🌟

Economic Analysis in Clinical Trials
                

Economics in Clinical Trials: A Guide to Value-Based Decisions

🔬📚 We’ve just published an insightful piece on the importance of economic analysis in clinical trials 💊. It’s not just about proving efficacy, but also about understanding the value💰that new treatments bring to the table.

In a world where value-based healthcare is becoming the norm, this kind of analysis is absolutely essential for informed decision-making. Dive into the article to learn more about the role of economic endpoints, trial design, and types of economic analysis in clinical trials.

Join the discussion and share your thoughts! #ClinicalTrials #EconomicAnalysis #HealthcareEconomics #ValueBasedCare 🌐👩‍⚕️👨‍⚕️

AI in Healthcare Risk Adjustment
            

The Influence of AI on Risk Adjustment Models in Healthcare

🚀 #HealthcareInnovation Alert! Our latest update reveals a groundbreaking ML algorithm transforming risk adjustment models. 🧬💡

🔍 With enhanced predictive accuracy & fairness, we’re paving the way for smarter, more efficient healthcare resource allocation. 💊💰

👨‍⚕️👩‍⚕️ Clinicians, #LifeSciencesExperts, and #HealthcareProfessionals, discover how this innovation could change the game for patient care and financial planning. 📈

📖 Read our full article and join the conversation! ➡️

#ArtificialIntelligence #MachineLearning #HealthcareData #RiskAdjustment #AIinHealthcare #ValueBasedHealthcare

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.